XOMA Royalty (XOMA) Current Assets (2010 - 2026)
XOMA Royalty's (XOMA) quarterly Current Assets came in at $118.7 million in Q1 2026, up 4.88% year-on-year from $113.2 million in Q1 2025, and up 1.27% quarter-over-quarter from $117.3 million in Q4 2025.
XOMA Royalty (XOMA) Current Assets (2010 - 2026) Analysis & Trends
XOMA Royalty has disclosed Current Assets across 17 years of filings, most recently posting $118.7 million for Q1 2026.
- Current Assets for Q1 2026 came in at $118.7 million, up 4.88% year-over-year; the trailing twelve-month figure through Mar 2026 was $118.7 million (up 4.88% YoY), and the FY2025 annual result was $117.3 million, down 6.64% from the prior year.
- Current Assets came in at $118.7 million for Q1 2026 at XOMA Royalty, up from $117.3 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $169.3 million in Q4 2023 to a low of $34.5 million in Q3 2023.
- The 5-year median for Current Assets is $110.7 million (2025), against an average of $103.8 million.
- Across the five-year window, Current Assets plunged 56.73% in 2023 and soared 360.86% in 2024, its largest moves.
- XOMA Royalty's Current Assets stood at $61.3 million in 2022, then surged by 176.42% to $169.3 million in 2023, then slipped by 25.82% to $125.6 million in 2024, then declined by 6.64% to $117.3 million in 2025, then gained by 1.27% to $118.7 million in 2026.
- The last three Current Assets figures came in at $118.7 million (Q1 2026), $117.3 million (Q4 2025), and $110.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | 37.31 Mn |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | 521.86 Mn |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 10.37 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 1.25 Bn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 3.59 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | 7.63 Mn |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 11.73 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 600.85 Mn |
| 10 | XOMA Royalty | 5.52 Mn | -60.56 Mn | - | 118.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 118.75 Mn |
| Dec 31, 2025 | 117.26 Mn |
| Sep 30, 2025 | 110.71 Mn |
| Jun 30, 2025 | 104.93 Mn |
| Mar 31, 2025 | 113.23 Mn |
| Dec 31, 2024 | 125.60 Mn |
| Sep 30, 2024 | 159.02 Mn |
| Jun 30, 2024 | 162.20 Mn |
| Mar 31, 2024 | 146.89 Mn |
| Dec 31, 2023 | 169.31 Mn |
| Sep 30, 2023 | 34.51 Mn |
| Jun 30, 2023 | 38.42 Mn |
| Mar 31, 2023 | 45.07 Mn |
| Dec 31, 2022 | 61.25 Mn |
| Sep 30, 2022 | 79.74 Mn |
| Jun 30, 2022 | 87.26 Mn |
| Mar 31, 2022 | 89.61 Mn |
| Dec 31, 2021 | 96.97 Mn |
| Sep 30, 2021 | 74.87 Mn |
| Jun 30, 2021 | 87.25 Mn |